[新聞] 智擎最新胰臟癌新藥進度
1.原文連結(必須檢附):
http://ppt.cc/T68W
2.原文內容:
Second-Line nal-IRI (MM-398) Shows Consistent Improvement in Clinical
Outcomes in Metastatic Pancreatic Cancer
JAN 16, 2015
A deeper dive of data from NAPOLI-1, a randomized, controlled, open-label
phase III trial conducted in patients with gemcitabine-refractory metastatic
pancreatic cancer, bolsters support for use of MM-398 plus 5-fluorouracil
(5-FU)/leucovorin over 5-FU/leucovorin in the second-line setting (Abstract
234). Patients who received at least 80% of planned treatment during the
first 6 weeks of the study achieved a 3.8-month improvement in survival when
MM-398 was added to the chemotherapy backbone, according to data presented by
Li-Tzong Chen, MD, PhD, of the National Institute of Cancer Research and the
National Health Research Institutes in Taiwan.
3.心得/評論(必需填寫):
原文未完 請連接網址
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 223.136.76.18
※ 文章網址: https://www.ptt.cc/bbs/Stock/M.1421481909.A.809.html
推
01/17 16:29, , 1F
01/17 16:29, 1F
→
01/17 16:31, , 2F
01/17 16:31, 2F
推
01/17 16:48, , 3F
01/17 16:48, 3F
推
01/17 16:51, , 4F
01/17 16:51, 4F
推
01/17 17:05, , 5F
01/17 17:05, 5F
推
01/17 17:05, , 6F
01/17 17:05, 6F
推
01/17 17:56, , 7F
01/17 17:56, 7F
推
01/17 18:15, , 8F
01/17 18:15, 8F
推
01/17 18:25, , 9F
01/17 18:25, 9F
推
01/17 18:29, , 10F
01/17 18:29, 10F
→
01/17 18:40, , 11F
01/17 18:40, 11F
推
01/17 19:06, , 12F
01/17 19:06, 12F
推
01/17 19:11, , 13F
01/17 19:11, 13F
→
01/17 19:16, , 14F
01/17 19:16, 14F
推
01/17 19:19, , 15F
01/17 19:19, 15F
推
01/17 19:23, , 16F
01/17 19:23, 16F
推
01/17 19:24, , 17F
01/17 19:24, 17F
→
01/17 19:27, , 18F
01/17 19:27, 18F
推
01/17 19:28, , 19F
01/17 19:28, 19F
推
01/17 19:30, , 20F
01/17 19:30, 20F
→
01/17 19:31, , 21F
01/17 19:31, 21F
→
01/17 19:33, , 22F
01/17 19:33, 22F
→
01/17 19:35, , 23F
01/17 19:35, 23F
→
01/17 19:35, , 24F
01/17 19:35, 24F
→
01/17 19:36, , 25F
01/17 19:36, 25F
推
01/17 19:37, , 26F
01/17 19:37, 26F
推
01/17 19:40, , 27F
01/17 19:40, 27F
→
01/17 19:40, , 28F
01/17 19:40, 28F
→
01/17 19:51, , 29F
01/17 19:51, 29F
推
01/17 19:54, , 30F
01/17 19:54, 30F
推
01/17 19:56, , 31F
01/17 19:56, 31F
推
01/17 19:58, , 32F
01/17 19:58, 32F
→
01/17 20:05, , 33F
01/17 20:05, 33F
→
01/17 20:08, , 34F
01/17 20:08, 34F
→
01/17 20:15, , 35F
01/17 20:15, 35F
→
01/17 20:15, , 36F
01/17 20:15, 36F
→
01/17 20:16, , 37F
01/17 20:16, 37F
→
01/17 20:16, , 38F
01/17 20:16, 38F
推
01/17 20:29, , 39F
01/17 20:29, 39F
還有 37 則推文
推
01/17 22:30, , 77F
01/17 22:30, 77F
推
01/17 22:48, , 78F
01/17 22:48, 78F
→
01/17 23:13, , 79F
01/17 23:13, 79F
→
01/17 23:14, , 80F
01/17 23:14, 80F
推
01/18 00:20, , 81F
01/18 00:20, 81F
推
01/18 01:20, , 82F
01/18 01:20, 82F
推
01/18 08:09, , 83F
01/18 08:09, 83F
→
01/18 09:05, , 84F
01/18 09:05, 84F
推
01/18 11:34, , 85F
01/18 11:34, 85F
→
01/18 16:07, , 86F
01/18 16:07, 86F
推
01/18 16:24, , 87F
01/18 16:24, 87F
→
01/18 16:26, , 88F
01/18 16:26, 88F
推
01/18 16:40, , 89F
01/18 16:40, 89F
→
01/18 16:51, , 90F
01/18 16:51, 90F
推
01/18 17:04, , 91F
01/18 17:04, 91F
→
01/18 17:04, , 92F
01/18 17:04, 92F
→
01/18 17:04, , 93F
01/18 17:04, 93F
→
01/18 17:04, , 94F
01/18 17:04, 94F
推
01/18 17:30, , 95F
01/18 17:30, 95F
→
01/18 18:47, , 96F
01/18 18:47, 96F
→
01/18 18:47, , 97F
01/18 18:47, 97F
推
01/18 18:50, , 98F
01/18 18:50, 98F
→
01/18 18:50, , 99F
01/18 18:50, 99F
→
01/18 18:52, , 100F
01/18 18:52, 100F
→
01/18 18:53, , 101F
01/18 18:53, 101F
推
01/18 19:33, , 102F
01/18 19:33, 102F
→
01/18 19:34, , 103F
01/18 19:34, 103F
推
01/18 19:40, , 104F
01/18 19:40, 104F
→
01/18 19:41, , 105F
01/18 19:41, 105F
→
01/18 19:41, , 106F
01/18 19:41, 106F
→
01/18 19:51, , 107F
01/18 19:51, 107F
→
01/18 19:52, , 108F
01/18 19:52, 108F
推
01/18 20:19, , 109F
01/18 20:19, 109F
推
01/18 20:53, , 110F
01/18 20:53, 110F
推
01/18 21:40, , 111F
01/18 21:40, 111F
推
01/18 21:45, , 112F
01/18 21:45, 112F
推
01/19 05:22, , 113F
01/19 05:22, 113F
推
01/19 11:07, , 114F
01/19 11:07, 114F
→
01/19 11:07, , 115F
01/19 11:07, 115F
→
01/19 11:08, , 116F
01/19 11:08, 116F
討論串 (同標題文章)